360Medlink
360Medlink is a pioneering software development company specializing in the creation of science-based Digital Health Platforms. They focus on SaaS ready Digital Medicines, Digital Therapeutics (DTx), and Software as Medical Device (SaMD). Their solutions are used by clients including pharmaceutical/biotech companies, government and private health agencies, and aim to improve care access, inclusion, and health equity. Their mission is to harness Digital Therapeutics to deliver personalized, accessible healthcare, especially for underserved communities, and their vision is to create a future where every individual finds their place in healthcare through Digital Medicines.
Industries
Nr. of Employees
small (1-50)
360Medlink
500 Place d’Armes, Suite 1800, Montréal, Québec, Canada H2Y 2W2
Products
Clinically validated virtual patient companion platform
Patient-facing digital companion providing personalized coaching, symptom guidance, appointment and medication reminders, telehealth access and gamified learning; configurable for disease-specific indications including oncology.
Image-based clinical measurement tool (SaMD)
Web and mobile SaMD that uses image analysis to estimate skin/body surface area and other image-derived measurements for clinical monitoring and trial workflows.
Clinical trial and investigator engagement portal
Scalable, secure web portal that centralizes trial content, visualizes site performance and provides investigator communication and document exchange.
Trial pipeline and portfolio management platform
Modular platform to manage trial pipelines, link pathways/compounds/trials/sites and search clinical programs by disease, pathway or trial.
Clinically validated virtual patient companion platform
Patient-facing digital companion providing personalized coaching, symptom guidance, appointment and medication reminders, telehealth access and gamified learning; configurable for disease-specific indications including oncology.
Image-based clinical measurement tool (SaMD)
Web and mobile SaMD that uses image analysis to estimate skin/body surface area and other image-derived measurements for clinical monitoring and trial workflows.
Clinical trial and investigator engagement portal
Scalable, secure web portal that centralizes trial content, visualizes site performance and provides investigator communication and document exchange.
Trial pipeline and portfolio management platform
Modular platform to manage trial pipelines, link pathways/compounds/trials/sites and search clinical programs by disease, pathway or trial.
Services
End-to-end development of tailored web and mobile digital health platforms delivered as SaaS, including design, engineering and deployment.
Regulatory strategy and support for digital therapeutics and SaMD across development stages, plus assistance with data privacy and security standards.
Design and execution of clinical evaluations, UX studies, program evaluations and analytics plans to generate evidence and optimise products.
API design and integration with sensor networks, external systems and programmatic infrastructures to support larger healthcare programs.
Development and integration of machine learning models to provide adaptive, smart application behaviors and clinical measurement tools.
Solutions and program support to promote clinical trials, match participants, improve enrollment and increase retention through digital engagement tools.
End-to-end development of tailored web and mobile digital health platforms delivered as SaaS, including design, engineering and deployment.
Regulatory strategy and support for digital therapeutics and SaMD across development stages, plus assistance with data privacy and security standards.
Design and execution of clinical evaluations, UX studies, program evaluations and analytics plans to generate evidence and optimise products.
API design and integration with sensor networks, external systems and programmatic infrastructures to support larger healthcare programs.
Development and integration of machine learning models to provide adaptive, smart application behaviors and clinical measurement tools.
Solutions and program support to promote clinical trials, match participants, improve enrollment and increase retention through digital engagement tools.
Expertise Areas
- Digital therapeutics (DTx) and SaMD development
- Digital clinical trial management and participant engagement
- AI/ML integration for healthcare
- User-centered design and behavioral science
Key Technologies
- Machine learning / AI
- Computer vision for clinical measurement
- Web and mobile application development
- API-driven interoperability
News & Updates
Press Release Montreal, Paris, New York. 360Medlink, a trailblazer in digital health platforms, and Rubix LS, a pioneer in clinical trial data intelligence and research, today announced a powerful partnership that promises to reshape the landscape of clinical trials. The collaboration aims to leverage Rubix LS’ data of over 11 million diverse and underserved patients and 360Medlink’s cutting-edge digital health platforms to drive inclusive, efficient, and groundbreaking clinical research programs. Together the companies combine a long list of clients in the life sciences industry.
Nous sommes fiers d’annoncer le lancement d’un nouveau module par TAVIEpso dans le domaine du rhumatisme psoriasique. Chez 360MedLink, nous nous engageons à fournir des solutions technologiques avancées pour améliorer la qualité de vie des patients.
We are excited to share the groundbreaking findings of the NASTAD evaluation report on the TAVIE Red Program. This comprehensive evaluation highlights the remarkable impact of our innovative program on enhancing HIV care engagement and adherence.
We are thrilled to share that 360Medlink recently attended the USCHA2022 conference held in Puerto Rico. This highly anticipated event featured over 120 institutes, workshops, and posters.
We are pleased to announce our collaboration with ICWNA (International Women Community) in their mission to empower and assist women living with HIV. As a firm believer in the power of partnerships, we are proud to contribute to their invaluable work.
We are delighted to announce that 360MedLink’s cutting-edge medical device software (MDD) has been nominated for the prestigious Galien Award in the Medtech category. This nomination reaffirms our position among top high-value life sciences innovations acknowledged by Galien France.
Press Release Montreal, Paris, New York. 360Medlink, a trailblazer in digital health platforms, and Rubix LS, a pioneer in clinical trial data intelligence and research, today announced a powerful partnership that promises to reshape the landscape of clinical trials. The collaboration aims to leverage Rubix LS’ data of over 11 million diverse and underserved patients and 360Medlink’s cutting-edge digital health platforms to drive inclusive, efficient, and groundbreaking clinical research programs. Together the companies combine a long list of clients in the life sciences industry.
Nous sommes fiers d’annoncer le lancement d’un nouveau module par TAVIEpso dans le domaine du rhumatisme psoriasique. Chez 360MedLink, nous nous engageons à fournir des solutions technologiques avancées pour améliorer la qualité de vie des patients.
We are excited to share the groundbreaking findings of the NASTAD evaluation report on the TAVIE Red Program. This comprehensive evaluation highlights the remarkable impact of our innovative program on enhancing HIV care engagement and adherence.
We are thrilled to share that 360Medlink recently attended the USCHA2022 conference held in Puerto Rico. This highly anticipated event featured over 120 institutes, workshops, and posters.
We are pleased to announce our collaboration with ICWNA (International Women Community) in their mission to empower and assist women living with HIV. As a firm believer in the power of partnerships, we are proud to contribute to their invaluable work.
We are delighted to announce that 360MedLink’s cutting-edge medical device software (MDD) has been nominated for the prestigious Galien Award in the Medtech category. This nomination reaffirms our position among top high-value life sciences innovations acknowledged by Galien France.